Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hothorn

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trialR-D Hofheinz, D Arnold, E Fokas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trialE Fokas, R Fietkau, A Hartmann, et al.
Spinal Cord|December 17, 2014
Challenges for defining minimal clinically important difference (MCID) after spinal cord injuryX Wu, J Liu, L G Tanadini, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trialR-D Hofheinz, D Arnold, E Fokas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trialE Fokas, R Fietkau, A Hartmann, et al.
Spinal Cord|December 17, 2014
Challenges for defining minimal clinically important difference (MCID) after spinal cord injuryX Wu, J Liu, L G Tanadini, et al.
Pageof 3